Papers

Stanford 团队 VirtualBiotech 登上 Science:数万个 AI 智能体协作做药物研发

https://t.co/Lvg7iH5c8n

Why we picked it

Stanford 的 James Zou 团队在 Science 上发了 VirtualBiotech,让数万个 AI 智能体像一家生物科技公司一样分工跑完从找靶点到设计临床试验的全流程。做药物研发的人和想搭多智能体系统的人都该看看,它是一份现成的 agentic R&D 组织蓝图。

Stanford 的 James Zou 团队在 Science 杂志发表论文,介绍 VirtualBiotech 系统,用数万个 AI scientist 智能体协作完成药物研发全流程。系统覆盖从靶点发现、药物设计到临床试验设计的完整链条,模拟真实生物医药公司的研发组织方式。

Body

技术上,系统将研发流程拆分为多个阶段,由智能体分工执行:早期阶段负责靶点识别与候选分子筛选,后期阶段负责试验方案设计,各阶段之间通过交接协作推进。作者将其称为一套 agentic R&D 的可复用蓝图。

对生物医药行业而言,这提供了一条把大规模多智能体系统引入研发流程的路径;对开发者而言,论文展示了如何按组织结构编排智能体,而不是单个模型独立完成任务。

Original · Claude

https://t.co/Lvg7iH5c8n

x.com/james_y_zou/st… James Zou @james_y_zou Super excited that #VirtualBiotech is published in @ScienceMagazine today! Tens of thousands of AI scientist agents work together across drug discovery + development, from target discovery to clinical trial design. Our blueprint for agentic R&D 🧵 🔗 View Quoted Tweet📊 2 ⚡

Industry Coordinates & Source Verification

This report is categorized under AITOP's "Papers" desk, focusing on US frontier AI labs and Silicon Valley technology leaders. Within our cross-regional analytical framework, it directly maps to AI developer toolchains, coding agents, and engineering workflows. Key entities and technical topics under continuous tracking include VirtualBiotech, AI scientist, agents, drug discovery.

Source attribution: curated from Claude (@claudeai).